GeneTex
United States (US)

SLC25A31 antibody

SLC25A31-antibody-GTX87816-WB-1_18121411_204.jpg

Cat No. GTX87816

Host Rabbit
Clonality Polyclonal
Application WB, ELISA
Reactivity Human, Mouse
APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Dilution
WB Assay dependent
ELISA Assay dependent
Not tested in other applications.

Calculated MW

35 kDa. ( Note )

Specificity/Sensitivity

SLC25A31 Antibody detects endogenous levels of total SLC25A31 protein.
PROPERTIES

Form

Liquid

Buffer

Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

Antigen Species

Human

Immunogen

The antiserum was produced against synthesized peptide derived from human SLC25A31.

Purification

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Conjugation

Unconjugated

Note

For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET

Synonyms

SLC25A31, Solute carrier family25 member31, ATP carrier protein 4, ANT 4, Adenine nucleotide translocator4, ADP/ATP translocase 4, Solute carrier family 25 member 31, ATP carrier protein4, ANT4, ADP, Adenine nucleotide translocator 4, ADP/ATP translocase4, Sperm flagellar energy carrier protein

Cellular Localization

In sperm flagellum this protein is located in the fibrous sheath, a non-mitochondrial region.

Background

Catalyzes the exchange of ADP and ATP across the mitochondrial inner membrane. May serve to mediate energy generating and energy consuming processes in the distal flagellum, possibly as a nucleotide shuttle between flagellar glycolysis, protein phosphorylation and mechanisms of motility.
Show More +

Database

Research Area

DATA IMAGES
SLC25A31-antibody-GTX87816-WB-1_18121411_204.jpg

GTX87816 WB Image

Western blot analysis of extracts from HeLa/HuvEc/COLO cells, using SLC25A31 Antibody. The lane on the right is treated with the synthesized peptide.